| scholarly article | Q13442814 |
| P2093 | author name string | Sanjay K Banerjee | |
| Ramu Adela | |||
| P2860 | cites work | A comprehensive review on metabolic syndrome | Q21284500 |
| MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily | Q24317134 | ||
| Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis | Q24321895 | ||
| Human cDNA Encoding a Novel TGF- Superfamily Protein Highly Expressed in Placenta | Q24322027 | ||
| The in vivo gene expression signature of oxidative stress | Q24653033 | ||
| Cardiokines: recent progress in elucidating the cardiac secretome | Q27022911 | ||
| The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
| Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
| Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury | Q28251154 | ||
| GDF15, a cardioprotective TGF-beta superfamily protein | Q28297925 | ||
| GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men | Q28535575 | ||
| Cardiac myocyte gene expression profiling during H2O2-induced apoptosis | Q28568243 | ||
| Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure | Q28591476 | ||
| Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets | Q28730588 | ||
| Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study | Q29614968 | ||
| Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum | Q30452357 | ||
| Adaptive Induction of Growth Differentiation Factor 15 Attenuates Endothelial Cell Apoptosis in Response to High Glucose Stimulus | Q31120253 | ||
| The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury | Q33231048 | ||
| Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline | Q33331460 | ||
| Macrophage inhibitory cytokine-1 regulates melanoma vascular development | Q33882542 | ||
| Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3 | Q58905267 | ||
| Human monocytes/macrophages release TNF-alpha in response to Ox-LDL | Q71930757 | ||
| Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension | Q73459068 | ||
| Altered plasma levels of cytokines in patients with ischemic heart disease | Q73544157 | ||
| MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma | Q73653083 | ||
| Topographical Association Between the Cyclin-Dependent Kinases Inhibitor P21, p53 Accumulation, and Cellular Proliferation in Human Atherosclerotic Tissue | Q73832976 | ||
| Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits | Q73966588 | ||
| Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3 | Q74346861 | ||
| Secreted and cell surface genes expressed in benign and malignant colorectal tumors | Q74590931 | ||
| MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation | Q77787092 | ||
| Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development | Q77846338 | ||
| Characterization of apoptotic macrophages in atheromatous tissue of humans and heritable hyperlipidemic rabbits | Q77920151 | ||
| Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association | Q78057327 | ||
| Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome | Q82921408 | ||
| Growth-differentiation factor-15: a novel biomarker in patients with diastolic dysfunction? | Q84126763 | ||
| Multimarker approach for the prediction of cardiovascular events in patients with mild to moderate coronary artery lesions. A 3-year follow-up study | Q84355521 | ||
| Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support | Q84658437 | ||
| The story of growth differentiation factor 15: another piece of the puzzle | Q85199125 | ||
| Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22 | Q85239091 | ||
| Growth-differentiation factor-15 and major cardiac events | Q87280167 | ||
| Usefulness of growth differentiation factor-15 levels to predict diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes mellitus | Q87466369 | ||
| Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis | Q87560591 | ||
| [Value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy] | Q95571566 | ||
| Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy | Q33932770 | ||
| Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53 | Q34025188 | ||
| NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism | Q34054078 | ||
| Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality | Q34072831 | ||
| Growth differentiation factor-15 (GDF-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass | Q34110286 | ||
| Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus | Q34206335 | ||
| Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression. | Q34228824 | ||
| TGF-beta in the cardiovascular system: molecular mechanisms of a context-specific growth factor | Q34294254 | ||
| Interventional studies concerning the role of antioxidant vitamins in cardiovascular diseases: a review | Q34310620 | ||
| The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction | Q34343385 | ||
| The Association of Growth Differentiation Factor-15 with Left Ventricular Hypertrophy in Hypertensive Patients | Q34447208 | ||
| Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case | Q34699836 | ||
| Cause-specific excess deaths associated with underweight, overweight, and obesity | Q34711194 | ||
| Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death | Q34986193 | ||
| The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study | Q35924547 | ||
| An immune origin of type 2 diabetes? | Q36112058 | ||
| Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer | Q36481328 | ||
| Modified low density lipoprotein delivers substrate for ceramide formation and stimulates the sphingomyelin-ceramide pathway in human macrophages | Q36852827 | ||
| GDF15 triggers homeostatic proliferation of acid-secreting collecting duct cells | Q36906059 | ||
| Potential biomarkers of ageing. | Q37061417 | ||
| PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway | Q37143062 | ||
| Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study | Q37588805 | ||
| Biomarkers of cardiovascular stress and incident chronic kidney disease | Q37678391 | ||
| Growth differentiation factor (GDF)-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation | Q37683299 | ||
| Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies | Q37960351 | ||
| Growth Differentiation Factor 15 in Heart Failure: An Update | Q38041973 | ||
| Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study). | Q38179689 | ||
| Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes | Q38345677 | ||
| Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARI | Q38422565 | ||
| Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial | Q39564409 | ||
| Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial. | Q39835614 | ||
| p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms | Q39902879 | ||
| Growth differentiation factor-15: a new biomarker in cardiovascular disease | Q39917432 | ||
| Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study | Q39967372 | ||
| Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis | Q40359911 | ||
| The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide | Q40408743 | ||
| The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome | Q40436424 | ||
| Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers | Q40568605 | ||
| Acute systemic inflammation impairs endothelium-dependent dilatation in humans | Q40616085 | ||
| Growth Differentiation Factor‐15 Deficiency Inhibits Atherosclerosis Progression by Regulating Interleukin‐6–Dependent Inflammatory Response to Vascular Injury | Q41831221 | ||
| Signaling of Reactive Oxygen and Nitrogen Species in Diabetes Mellitus | Q41870434 | ||
| Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis | Q42288906 | ||
| Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent | Q42543771 | ||
| Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes | Q42805165 | ||
| Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study | Q43157318 | ||
| Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer | Q43708520 | ||
| Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai | Q44201376 | ||
| Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. | Q44564112 | ||
| Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts | Q44871151 | ||
| Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions | Q45086910 | ||
| Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction | Q45173402 | ||
| Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes | Q45177029 | ||
| Multiple marker approach to risk stratification in patients with stable coronary artery disease | Q45573743 | ||
| Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. | Q45974276 | ||
| Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery | Q46527093 | ||
| High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway | Q46560274 | ||
| Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program | Q46833890 | ||
| Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis | Q47780850 | ||
| Growth differentiation factor-15 in the early diagnosis and risk stratification of patients with acute chest pain | Q48742918 | ||
| Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction | Q48788412 | ||
| Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. | Q48960842 | ||
| Increased number of islet-associated macrophages in type 2 diabetes. | Q53545508 | ||
| Growth differentiation factor 15, ischemia modified albumin and pregnancy-associated plasma protein A in patients with coronary artery disease. | Q54338426 | ||
| GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. | Q54623768 | ||
| Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome | Q56593478 | ||
| Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo | Q57248441 | ||
| Polarised secretion of cytokines in primary human microvascular endothelial cells is not dependent on N-linked glycosylation | Q57359961 | ||
| Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure | Q57422717 | ||
| Colocalization of CPP-32 With Apoptotic Cells in Human Atherosclerotic Plaques | Q58150467 | ||
| The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients | Q58788278 | ||
| GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice | Q58807888 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| diabetes | Q12206 | ||
| peptide | Q172847 | ||
| cardiovascular disease | Q389735 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 490842 | |
| P577 | publication date | 2015-07-27 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Diabetes Research | Q26841822 |
| P1476 | title | GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective | |
| P478 | volume | 2015 |
| Q42745683 | A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart. |
| Q64099112 | Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis |
| Q92218212 | Association between Growth Differentiation Factor 15 and Non-Dipping Circadian Pattern in Patients with Newly Diagnosed Essential Hypertension |
| Q48359696 | Biomarkers for cardiovascular risk in patients with diabetes |
| Q55486841 | CRP Stimulates GDF15 Expression in Endothelial Cells through p53. |
| Q52425192 | Cigarette Smoke Induces Human Airway Epithelial Senescence via Growth Differentiation Factor 15 Production |
| Q37060780 | Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosis |
| Q55285033 | Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data. |
| Q90908560 | Circulating growth-and-differentiation factor-15 in early life: relation to prenatal and postnatal growth and adiposity measurements |
| Q64974281 | Circulating growth/differentiation factor 15 is associated with human CD56bright natural killer cell dysfunction and nosocomial infection in severe systemic inflammation. |
| Q33921756 | Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus |
| Q95933350 | Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial |
| Q93175092 | Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma |
| Q47702192 | Effect of metformin and celecoxib on cytotoxicity and release of GDF-15 from human mesenchymal stem cells in high glucose condition |
| Q61449764 | Elevated Serum Growth Differentiation Factor 15 Levels in Hyperthyroid Patients |
| Q50045976 | Endothelial transcriptomics reveals activation of fibrosis-related pathways in hypertension |
| Q41110363 | Epigenetic alterations in patients with type 2 diabetes mellitus |
| Q54179932 | Epigenome-wide association study reveals differential DNA methylation in individuals with a history of myocardial infarction |
| Q51246528 | Fasting exacerbates hepatic growth differentiation factor 15 to promote fatty acid β-oxidation and ketogenesis via activating XBP1 signaling in liver |
| Q53420692 | Further Evidence of Accelerated Aging in Bipolar Disorder: Focus on GDF-15. |
| Q33362887 | GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients |
| Q58697982 | GDF15 Regulates Malat-1 Circular RNA and Inactivates NFκB Signaling Leading to Immune Tolerogenic DCs for Preventing Alloimmune Rejection in Heart Transplantation |
| Q59807334 | GDF15 and Growth Control |
| Q37702121 | GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway |
| Q92033378 | Gdf15 regulates murine stress erythroid progenitor proliferation and the development of the stress erythropoiesis niche |
| Q42373707 | Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease |
| Q96640645 | Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy |
| Q33682931 | Growth Differentiation Factor-15 Deficiency Augments Inflammatory Response and Exacerbates Septic Heart and Renal Injury Induced by Lipopolysaccharide |
| Q91727617 | Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach |
| Q95338257 | Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player |
| Q57802372 | Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer-Cardiovascular Cohort |
| Q47121253 | Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling |
| Q54979361 | Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study. |
| Q90369225 | Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study |
| Q55095988 | Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study. |
| Q37049765 | Growth differentiation factor-15 promotes glutamate release in medial prefrontal cortex of mice through upregulation of T-type calcium channels |
| Q89793794 | Hypoxia Induces Growth Differentiation Factor 15 to Promote the Metastasis of Colorectal Cancer via PERK-eIF2α Signaling |
| Q101121020 | IL-18 binding protein (IL-18BP) as a novel radiation countermeasure after radiation exposure in mice |
| Q93055320 | Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis |
| Q61809470 | Imbalance of erythropoiesis and iron metabolism in patients with thalassemia |
| Q93035140 | Keratinocytes Derived from Patient-Specific Induced Pluripotent Stem Cells Recapitulate the Genetic Signature of Psoriasis Disease |
| Q57285536 | Linking cellular stress responses to systemic homeostasis |
| Q59329214 | Maternal Diabetes and Fetal Programming Toward Neurological Diseases: Beyond Neural Tube Defects |
| Q93192737 | Metabolic remodeling induced by mitokines in heart failure |
| Q97559552 | Multimarker approach including CRP, sST2 and GDF-15 for prognostic stratification in stable heart failure |
| Q92637648 | Novel Biochemical Markers of Neurovascular Complications in Type 1 Diabetes Patients |
| Q64980655 | On the role of macrophages in the control of adipocyte energy metabolism. |
| Q55405827 | Parallel Genome-wide Profiling of Coding and Non-coding RNAs to Identify Novel Regulatory Elements in Embryonic and Maturated Heart. |
| Q58705640 | Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches |
| Q102326360 | Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection |
| Q41367462 | Plasma GDF15 level is elevated in psychosis and inversely correlated with severity |
| Q53728725 | Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease |
| Q104681912 | Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis |
| Q41373043 | Preoperative plasma growth-differentiation factor-15 for prediction of acute kidney injury in patients undergoing cardiac surgery. |
| Q55343200 | Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers. |
| Q102388807 | Relationship between plasma growth differentiation factor-15 levels and diabetic retinopathy in individuals with type 2 diabetes |
| Q92289959 | Role of GDF15 in active lifestyle induced metabolic adaptations and acute exercise response in mice |
| Q97526996 | Serum GDF15, a Promising Biomarker in Obese Patients Undergoing Heart Surgery |
| Q35967535 | Soluble Forms of Intercellular and Vascular Cell Adhesion Molecules Independently Predict Progression to Type 2 Diabetes in Mexican American Families |
| Q38818709 | The Cross-Link between Adipokines, Insulin Resistance and Obesity in Offspring of Diabetic Pregnancies |
| Q90718919 | The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes |
| Q38605925 | The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. |
| Q61798293 | Tocotrienol-Rich Fraction (TRF) Treatment Promotes Proliferation Capacity of Stress-Induced Premature Senescence Myoblasts and Modulates the Renewal of Satellite Cells: Microarray Analysis |
| Q48574810 | Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity |
Search more.